Interpace Diagnostics Group Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
47,600.00
23,218.00
8,804.00
602.00
15,199.00
6,068
Total Accounts Receivable
10,404.00
14,423.00
4,214.00
2,534.00
3,437.00
9,483
Other Current Assets
4,705.00
7,225.00
6,147.00
1,104.00
1,172.00
2,170
Total Current Assets
62,709.00
44,866.00
19,165.00
4,240.00
19,808.00
17,721
Net Property, Plant & Equipment
2,789.00
3,184.00
1,460.00
929.00
654.00
837
Total Investments and Advances
370.00
1,057.00
905.00
-
-
-
Intangible Assets
2,523.00
62,849.00
43,492.00
36,358.00
33,105.00
29,853
Other Assets
673.00
3,950.00
2,690.00
251.00
31.00
31
Total Assets
69,064.00
115,906.00
67,712.00
41,778.00
53,598.00
48,442
ST Debt & Current Portion LT Debt
-
-
1,164.00
-
-
Accounts Payable
2,350.00
4,308.00
1,560.00
2,326.00
391.00
Other Current Liabilities
29,050.00
29,270.00
20,649.00
13,915.00
7,700.00
Total Current Liabilities
31,400.00
33,578.00
23,373.00
16,241.00
8,091.00
Long-Term Debt
-
27,154.00
7,233.00
7,908.00
-
Provision for Risks & Charges
4,074.00
29,176.00
21,315.00
10,848.00
5,083.00
Deferred Taxes
-
2,525.00
-
-
-
Other Liabilities
1,111.00
3,351.00
2,753.00
250.00
555.00
Total Liabilities
36,585.00
95,784.00
54,674.00
35,247.00
13,729.00
Common Equity (Total)
32,479.00
20,122.00
13,038.00
6,531.00
39,869.00
Total Shareholders' Equity
32,479.00
20,122.00
13,038.00
6,531.00
39,869.00
Total Equity
32,479.00
20,122.00
13,038.00
6,531.00
39,869.00
Liabilities & Shareholders' Equity
69,064.00
115,906.00
67,712.00
41,778.00
53,598.00
About Interpace Diagnostics Group
View Profile
